Literature DB >> 3025256

Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro.

K L Moore, S P Andreoli, N L Esmon, C T Esmon, N U Bang.   

Abstract

Endotoxemia is frequently associated clinically with disseminated intravascular coagulation (DIC); however, the mechanism of endotoxin action in vivo is unclear. Modulation of tissue factor (TF) and thrombomodulin (TM) expression on the endothelial surface may be relevant pathophysiologic mechanisms. Stimulation of human umbilical vein endothelial cells with endotoxin (1 microgram/ml) increased surface TF activity from 1.52 +/- 0.84 to 11.89 +/- 8.12 mU/ml-10(6) cells at 6 h (n = 11) which returned to baseline by 24 h. Repeated stimulation at 24 h resulted in renewed TF expression. Endotoxin (1 microgram/ml) also caused a decrease in TM expression to 55.0 +/- 6.4% of control levels at 24 h (n = 10) that remained depressed at 48 h. Both effects were dose and serum dependent. A temporary rise in TF expression accompanied by a sustained fall in TM expression comprise a shift in the hemostatic properties of the endothelium that would favor intravascular coagulation and may contribute to the pathogenesis of DIC in gram-negative septicemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025256      PMCID: PMC424004          DOI: 10.1172/JCI112772

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity.

Authors:  P P Nawroth; D A Handley; C T Esmon; D M Stern
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

2.  Deleterious effects of endotoxin on cultured endothelial cells: an in vitro model of vascular injury.

Authors:  O Yamada; C F Moldow; T Sacks; P R Craddock; M A Boogaerts; H S Jacob
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

3.  Binding of factors IX and IXa to cultured vascular endothelial cells.

Authors:  D M Stern; M Drillings; H L Nossel; A Hurlet-Jensen; K S LaGamma; J Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

4.  Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets.

Authors:  J H Brox; B Osterud; E Bjørklid; J W Fenton
Journal:  Br J Haematol       Date:  1984-06       Impact factor: 6.998

5.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

6.  Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells.

Authors:  D J Loskutoff; J A van Mourik; L A Erickson; D Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

Review 7.  Clinical studies of protein C.

Authors:  J H Griffin
Journal:  Semin Thromb Hemost       Date:  1984-04       Impact factor: 4.180

8.  Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V.

Authors:  C A Fulcher; J E Gardiner; J H Griffin; T S Zimmerman
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

9.  Purification and properties of human coagulation factor VII.

Authors:  G J Broze; P W Majerus
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

10.  Cultured human endothelial cells generate tissue factor in response to endotoxin.

Authors:  M Colucci; G Balconi; R Lorenzet; A Pietra; D Locati; M B Donati; N Semeraro
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

View more
  63 in total

1.  Functional heterogeneity of anti-endothelial cell antibodies.

Authors:  A Bordron; R Révélen; F D'Arbonneau; M Dueymes; Y Renaudineau; C Jamin; P Youinou
Journal:  Clin Exp Immunol       Date:  2001-06       Impact factor: 4.330

Review 2.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

3.  Effect of E. coli endotoxin on mammalian cell growth and recombinant protein production.

Authors:  J Epstein; M M Lee; C E Kelly; P K Donahoe
Journal:  In Vitro Cell Dev Biol       Date:  1990-12

Review 4.  The endothelium: physiological functions and role in microcirculatory failure during severe sepsis.

Authors:  H Ait-Oufella; E Maury; S Lehoux; B Guidet; G Offenstadt
Journal:  Intensive Care Med       Date:  2010-05-05       Impact factor: 17.440

5.  Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin.

Authors:  W A Dittman; T Kumada; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains.

Authors:  M Maruno; T Yoshimine; T Isaka; R Kuroda; H Ishii; T Hayakawa
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Tissue factor is rapidly induced in arterial smooth muscle after balloon injury.

Authors:  J D Marmur; M Rossikhina; A Guha; B Fyfe; V Friedrich; M Mendlowitz; Y Nemerson; M B Taubman
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

8.  Role of cyclic AMP in promoting the thromboresistance of human endothelial cells by enhancing thrombomodulin and decreasing tissue factor activities.

Authors:  G Archipoff; A Beretz; K Bartha; C Brisson; C de la Salle; C Froget-Léon; C Klein-Soyer; J P Cazenave
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis.

Authors:  T A Drake; J Cheng; A Chang; F B Taylor
Journal:  Am J Pathol       Date:  1993-05       Impact factor: 4.307

Review 10.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.